Dr. Aşkın Şeker ist ein hoch angesehener Neurochirurg mit über 23 Jahren Erfahrung und zahlreichen Auszeichnungen und Erfolgen. Er interessiert sich für endoskopische Schädelbasischirurgie, Neuroanatomie, funktionelle Neurochirurgie, Bewegungsstörungen, Wirbelsäulenchirurgie, Bandscheibenvorfall, Halshernie und endoskopische Operationen. Er ist Mitglied zahlreicher Berufsverbände und hat 47 Artikel in internationalen SCI-Zeitschriften veröffentlicht, Artikel auf 33 internationalen wissenschaftlichen Tagungen präsentiert, 10 Artikel in nationalen Zeitschriften geschrieben und Kapitel für 2 internationale Bücher geschrieben.
Mehr lesenDr. Aşkın Şeker ist ein hoch angesehener Neurochirurg mit über 23 Jahren Erfahrung und zahlreichen Auszeichnungen und Erfolgen. Er interessiert sich für endoskopische Schädelbasischirurgie, Neuroanatomie, funktionelle Neurochirurgie, Bewegungsstörungen, Wirbelsäulenchirurgie, Bandscheibenvorfall, Halshernie und endoskopische Operationen. Er ist Mitglied zahlreicher Berufsverbände und hat 47 Artikel in internationalen SCI-Zeitschriften veröffentlicht, Artikel auf 33 internationalen wissenschaftlichen Tagungen präsentiert, 10 Artikel in nationalen Zeitschriften geschrieben und Kapitel für 2 internationale Bücher geschrieben.
| Arztbesuch | preis auf anfrage |
| Entfernung von Hirntumoren | $20000 - $50000 |
| Gamma Knife für Hirntumor | $6500 |
| CyberKnife für Hirntumor | $6500 |
Dr. Venus Rawat ist Fachärztin für HNO mit MS in HNO und MBBS. Sie hat Erfahrung in der Arbeit in indischen Krankenhäusern und ein Stipendium für Schlafapnoe-Chirurgie aus Singapur. Ihre besonderen Interessen umfassen endoskopische und mikroskopische Ohrchirurgie, Myringotomie und Grommet-Einführung, endoskopische Nasennebenhöhlenchirurgie, Septumplastik, Turbinoplastik, Entfernung von Mandeln und Adenoiden mit der Koblationstechnik, Schnarchen und obstruktive Schlafapnoe-Chirurgie, Mikrolarynxchirurgie und Schwindelmanagement.
Mehr lesenDr. Venus Rawat ist Fachärztin für HNO mit MS in HNO und MBBS. Sie hat Erfahrung in der Arbeit in indischen Krankenhäusern und ein Stipendium für Schlafapnoe-Chirurgie aus Singapur. Ihre besonderen Interessen umfassen endoskopische und mikroskopische Ohrchirurgie, Myringotomie und Grommet-Einführung, endoskopische Nasennebenhöhlenchirurgie, Septumplastik, Turbinoplastik, Entfernung von Mandeln und Adenoiden mit der Koblationstechnik, Schnarchen und obstruktive Schlafapnoe-Chirurgie, Mikrolarynxchirurgie und Schwindelmanagement.
Dr. Saurabh Singh ist ein erfahrener Augenarzt mit mehr als 11 Jahren Erfahrung und Fachwissen in den Bereichen umfassende Augenuntersuchungen, computergestützte Augentests, Lasik, Kataraktchirurgie, Hornhauttransplantation, Augenoberflächenrekonstruktion, Keratoprothese, Keratokonus-Management und Glaukom-Management. Er hat sowohl nationale als auch internationale Publikationen und ist regelmäßiger Gastredner bei wissenschaftlichen Tagungen und CDEs.
Mehr lesenDr. Saurabh Singh ist ein erfahrener Augenarzt mit mehr als 11 Jahren Erfahrung und Fachwissen in den Bereichen umfassende Augenuntersuchungen, computergestützte Augentests, Lasik, Kataraktchirurgie, Hornhauttransplantation, Augenoberflächenrekonstruktion, Keratoprothese, Keratokonus-Management und Glaukom-Management. Er hat sowohl nationale als auch internationale Publikationen und ist regelmäßiger Gastredner bei wissenschaftlichen Tagungen und CDEs.
| Arztbesuch | preis auf anfrage |
| Allogene Knochenmarktransplantation von einem nicht verwandten Spender | $110000 |
| Allogene Knochenmarktransplantation von einem verwandten Spender | $75000 |
| Entfernung von Hirntumoren | $14000 - $22000 |
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:
Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:
Cell therapies in childhood cancers
Cancer immunology
Investigation of genetic pathways responsible for cancer and metastasis
Pulmonary microbiota
BAL transplantation
Mehr lesenSema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:
Cell therapies in childhood cancers
Cancer immunology
Investigation of genetic pathways responsible for cancer and metastasis
Pulmonary microbiota
BAL transplantation
Pediatric Hematology Oncology
Work Experience and Education
Istanbul University Faculty of Medicine - Medical Education
Children Health and Diseases Training and Research Hospital - Children's Oncology - Expertise
Children Health and Diseases Training and Research Hospital - Pediatric HematologyOncology - Minor Specialization
Children Health and Diseases Training and Research Hospital - Pediatric HematologyOncology - Associate Professor
Medical Field of Interest and Activities
Bone marrow transplantation
Childhood cancer
Leukemia Vascular Anomalies (vascular disorders)
Mehr lesenPediatric Hematology Oncology
Work Experience and Education
Istanbul University Faculty of Medicine - Medical Education
Children Health and Diseases Training and Research Hospital - Children's Oncology - Expertise
Children Health and Diseases Training and Research Hospital - Pediatric HematologyOncology - Minor Specialization
Children Health and Diseases Training and Research Hospital - Pediatric HematologyOncology - Associate Professor
Medical Field of Interest and Activities
Bone marrow transplantation
Childhood cancer
Leukemia Vascular Anomalies (vascular disorders)
| Arztbesuch | preis auf anfrage |
| Transnasale Resektion des Tumors | $35000 - $80000 |
| Entfernung von Hirntumoren | $35000 - $80000 |